Vitamin B12 levels and its binding capacity in the synovial fluid of the patients with joint diseases have been investigated, and the presence of vitamin B12 and its binding capacity in the synovial fluid have been demonstrated. Synovial B12 levels in the patients with rheumatoid arthritis were much lower than those in osteoarthritis, whereas B12 binding capacity in the synovial fluid of rheumatoid arthritis was higher than that in osteoarthritis.
Since vitamin B12 was recognized to have a remarkable effect on pernicious anemia (1), its characteristics have been investigated in many respects from the biochemical and clinical aspects, but much less information is available concerning the presence of vitamin B12 in the synovial fluid of human subjects.
In the present study, the authors attempted, for the first time, to determine the presence of vitamin B12 and its binding capacity in the synovial fluid of the patients with joint diseases.
MATERIALS AND METHODS
For this study, patients with classical rheu matoid arthritis were chosen who would f ullfill the criteria of the American Rheumatism Asso ciation. Synovial fluid was taken from the patient with osteoarthritis and rheumatoid arthritis.
Vitamin B12 concentration in the synovial fluid was determined according to the methods of Ford (2), Kamikubo (3) In the present study, we have verified, for the first time, the presence of vitamin B12 in the synovial fluid and its binding capacity and that there are significant differences in synovial B12 levels between rheumatoid arthritis and osteoarthritis (P<0.01).
These results indicate that low levels of B12 in the synovial fluid are characteristic findings in rheumatoid arthritis and that B12 probably participates in the appea rance of clinical features of rheumatoid arthritis. However, synovial B12 binding capacity in the rheumatoid arthritis was higer than that in osteoarthritis (P<0.01).
It is presumed that synovial B12 levels in the rheumatoid arthritis are insufficient and, subsequently, B12 binding capacity is increased compensationally to normal ize the synovial metabolism. Sugiyama (5) reported a decrease of ribo flavin contents in the synovial fluid and blood in the patients with rheumatoid arthritis as compared with those in osteoarthritis of healthy subjects, and suggested that lowering of phos phorylation of riboflavin in the blood and syno vial fluid in the rheumatoid arthritis resulted from disorder of the pituitary adrenal axis.
Gough et al. (6) reported that patients with rheumatoid arthritis may develop megaloplastic anemia due to a deficiency of or greater need for folic acid.
Fukui (7) recently reported that there are close relationships between B12 metabolism and rheumatoid arthritis from the changes in 57Co cyanocobalamin distribution in the organs and the BS2 binding capacity of rat stomach receiv ing the treatment of oral administration of synovial fluid of rheumatoid arthritis.
Furthermore, we (8) reported that blood B12 levels in a few patients with rheumatoid arthritis were low as compared with those in osteoar thritis and suggested that it may play some role in the development of rheumatoid arthritis.
